期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundAccurate staging and response assessment are essential for prognosis and to guide treatment in patients with lymphoma. The aim of this study......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundAlthough MRI is a radiation-free imaging modality, it has historically been limited in lung imaging due to inherent technical restrictions. ......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundCT prediction of resectability and prognosis following neoadjuvant treatment (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) ......
期刊： CANCER IMAGING, 2023; 23 (1)
Purpose Prostate-specific membrane antigen (PSMA) ligands targeting has shown promising results in staging of prostate cancer (PCa). The aim of presen......
期刊： CANCER IMAGING, 2023; 23 (1)
Objective To assess the effect of preoperative MRI with standardized Prostate Imaging-Reporting and Data System (PI-RADS) assessment on pathological o......
期刊： CANCER IMAGING, 2023; 23 (1)
Background To investigate the value of [18F]FDG-PET/MRI in predicting treatment response and survival in patients with primary M0 esophageal squamous ......
期刊： CANCER IMAGING, 2023; 23 (1)
Background PET/MRI is an emerging imaging modality which enables the evaluation and quantification of biochemical processes in tissues, complemented w......
期刊： CANCER IMAGING, 2023; 23 (1)
Objective To investigate the role of preoperative body composition analysis for muscle and adipose tissue distribution on long-term oncological outcom......
期刊： CANCER IMAGING, 2023; 23 (1)
PurposeTo compare different response criteria using computed tomography (CT) and positron emission tomography (PET) in measuring response and survival......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundThe advent of next-generation computed tomography (CT)- and magnetic resonance imaging (MRI) opened many new perspectives in the evaluation ......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundTo build and validate a radiomics nomogram based on preoperative CT scans and clinical data for detecting synchronous ovarian metastasis (SO......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundThe aim of this work is to evaluate the performance of radiomics predictions for a range of molecular, genomic and clinical targets in patie......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundHypoperfusion or resultant hypoxia in solid tumours is a main reason for therapeutic resistance. Augmenting the blood perfusion of hypovascu......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundLoss of muscle mass is the most common complication of end-stage liver disease and negatively affects outcomes for liver transplantation (LT......
期刊： CANCER IMAGING, 2023; 23 (1)
BackgroundOur study aimed to explore the potential of radiomics features derived from CT images in predicting the prognosis and response to adjuvant c......
